Year: 2021
Type: editorial
Source: Oncotarget
Authors: Vivek Subbiah, Razelle Kurzrock
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funders: Cancer Prevention and Research Institute of Texas, Andrew Sabin Family Foundation, National Institutes of Health, University of Texas MD Anderson Cancer Center, Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, National Cancer Institute, National Center for Advancing Translational Sciences, Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
Awards: G122915289, G1305542662, Informatics to enable routine personalized cancer therapy, G1468253849, G1543354196, Center for Clinical and Translational Sciences (CCTS), G2198050828, G2215946451, G293715275, G3191371094, G3880756689, G4276892241, G4512916930, G4587408335, G496938529, G4978893582, G5819141951, G6138997317, G6736661663, Blocking tumor progression in therapy-responsive RET aberration-associated cancer, G7410936242, G7436411625, G788993117, G8692209788, G8941877087, G8993335421, G9000315460, Cancer Center Support Grant
OpenAlex ID: W3209772204